Next Article in Journal
A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications
Previous Article in Journal
Targeting BRAF Activation as Acquired Resistance Mechanism to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small-Cell Lung Cancer
Previous Article in Special Issue
Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood–Brain Barrier
 
 
Review

Article Versions Notes

Pharmaceutics 2021, 13(9), 1479; https://doi.org/10.3390/pharmaceutics13091479
Action Date Notes Link
article pdf uploaded. 15 September 2021 16:55 CEST Version of Record https://www.mdpi.com/1999-4923/13/9/1479/pdf-vor
article xml file uploaded 16 September 2021 05:09 CEST Original file -
article xml uploaded. 16 September 2021 05:09 CEST Update https://www.mdpi.com/1999-4923/13/9/1479/xml
article pdf uploaded. 16 September 2021 05:09 CEST Updated version of record https://www.mdpi.com/1999-4923/13/9/1479/pdf
article html file updated 16 September 2021 05:10 CEST Original file -
article html file updated 30 July 2022 06:01 CEST Update https://www.mdpi.com/1999-4923/13/9/1479/html
Back to TopTop